[Prolactinemia and predictability of therapeutic response of schizophrenic patients in acute decompensation].
Vanelle
J M
JM
Service Hospitalo-Universitaire de Santé Mentale et de Thérapeutique (Service des Prs H. Lôo et J.P. Olié), Centre Hospitalier Sainte-Anne, Paris, France.
Amorim
P
P
Piketti
M L
ML
Bourdel
M C
MC
Poirier-Littré
M F
MF
D000208:Acute Disease; D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006220:Haloperidol / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008297:Male; D011379:Prognosis; D011388:Prolactin / Q000097:blood*; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D011388:Prolactin; D006220:Haloperidol
Prolactinémie et prédictivité de la réponse thérapeutique chez des schizophrènes en décompensation aiguë.